53 y/o Upper abd pain/burning, reflux 9/2011 – EGD – polypoid lesion in stomach on EGD, started on omeprazole – Path – carcinoid, invasive to muscularis,

Slides:



Advertisements
Similar presentations
Klara Matijević Mentor: A. Žmegač Horvat.  adenocarcinoma  gastrointestinal stromal tumours (GIST)  primary gastric lymphoma  gastric polyps.
Advertisements

T1 colonic carcinoma – Is endoscopic resection sufficient? HC Yip JHGR 21/7/2012.
Polyps – Where do they come from and what do you do with them?!
Neuroendocrine tumours of the stomach Case discussion.
Carcinoma of the Cardia: Is there progress in the management of non-Barrett’s cancer Spanish Association of Surgeons Madrid 11 November 2002 The University.
P ETER J. D I P ASCO, MD A SSISTANT P ROFESSOR OF S URGERY D EPARTMENT OF S URGERY – S ECTION OF S URGICAL O NCOLOGY T HE U NIVERSITY OF K ANSAS M EDICAL.
Prof. Faisal Ghani Siddiqui FCPS; PGDip-bioethics; MCPS-HPE
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
Endoscopic Mucosal Resection Dr. Howard Mertz Clinical Assistant Professor Vanderbilt University Saint Thomas Hospital Nashville TN.
Management of Difficult Colonic Lesions
Gastrointestinal Stromal Tumor
RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Characteristics of submucosal gastric carcinoma with lymph node metastatic disease H J Son, S Y Song,1 S Kim,3 J H Noh,2 T S Sohn,2 D S Kim1 & J C Rhee.
Dr. LF Hung Department of Surgery, Tuen Mun Hospital, HKSAR
Reporting and Management of Early stage Colorectal Cancer Frank Carey Dundee.
Colorectal cancer Khayal AlKhayal MD,FRCSC
Gastric Carcinoma.
Treatment of Early Malignant Rectal Polyp
A REVISIT TO MANAGEMENT OF GASTROINTESTINAL STROMAL TUMOUR (GIST) Joint Hospital Surgical Grand Round 17 Jan 2015 Grace Liu Pamela Youde Nethersole Eastern.
Gastric Cancer Matt White AM Report April 19, 2010.
Colorectal carcinoma Dr.Mohammadzadeh.
Dr Poonam Valand, Foundation Year Two Dr Anjan Dhar, Consultant Gastroenterologist COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST Early gastric cancer.
PANCREATIC CANCER.
A 72 y/o male with h/o CAD, NIDDM & mild GERD for 6-7 yrs on occasional PPI who started to have intermittent solid food dysphagia for few weeks. His EGD.
Moderators: David Cort, MD Alex Denes, MD Panelists: Stephen Swisher, MD, PhD Edward Lin, MD.
NEOPLASMS OF THE STOMACH
Gastric Cancer Gidon Almogy MD Department of General Surgery Hadassah University Hospital.
Joint Hospital Surgical Grand Round 1/2010 Neuroendocrine Tumour of Pancreas Chan Hoi Yee Princess Margaret Hospital.
External Ear Basosquamous cell carcinoma 1 Instructor: 杜宗陽主任 Reporter: 張廷碩.
The “Hand” of Appendix Cancer Presented to American Association of Primary Care Endoscopy Brian W. Meeker, D.O. Vinton, Ia. 53 y/o male presents for “screening”
Surgical Oncology Surgical Oncology 05/06/12 – 05/12/2012 David Williams Andy Young Ashley Limkemann Yula Dzhashiashvili.
Gastric ‘Polyposis’ Case Report Medical Trust Hospital, Kochi.
Supplemental Digital Content Figure 1A A Academic/Research Program Extent of Lung Resection No. of SubjectEventCensored Median Survival (95% CI)60 mo Survival.
Role/ Indications for surgery. Indications for surgery in PUD Bleeding Perforation Obstruction Intractability or nonhealing Schwartz’s Principles of Surgery,
Gastric Carcinoma. Background  Second most common cancer-related death.  Korea, Japan, China, Taiwan high rates.  22,000 diagnosed annually in US.
Endoluminal Treatment of Barrett’s and Early Cancer Brant K. Oelschlager, MD University of Washington.
위암병리보고서의 기재사항 서울대학교 김 우 호.
Case 1 현 O 훈 (M/34). Diagnosis : Stomach, distal gastrectomy: Signet ring cell carcinoma 1) Location: Angle 2) Tumor gross type: Early.
Case 1. Diagnosis : A. Colon, transverse, mid, endoscopic mucosal resection: Tubular adenoma with low grade dysplasia with 1) Size: 1.2 x 1.0.
Kyung Hee University, Seoul, Korea GI Conference UGI Conference Presented by Byeong-Joo Noh Supervised by Youn-Wha Kim Kyung Hee University, Seoul, Korea.
Case 1. Diagnosis : Stomach, resection margin, proximal, FS-1, biopsy: No tumor Stomach, resection margin, distal, FS-2, biopsy: Adenocarcinoma Lymph.
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
GI conference Case 3 Stomach and liver F/69 S
Risk of high-grade dysplasia or carcinoma in gastric biopsy-proven low-grade dysplasia: an analysis using the Vienna classification R1 김진숙 / Prof. 장재영.
Department of Pathology R3 NKY Case 1.
Should Elderly Patients Undergo Additional Surgery After Non-Curative Endoscopic Resection for Early Gastric Cancer? Long-Term Comparative Outcomes R3.
Long-term outcomes of combination of endoscopic submucosal dissection and laparoscopic lymph node dissection without gastrectomy for early gastric cancer.
Significance of Neoplastic Involvement of Margins Obtained by Endoscopic Mucosal Resection in Barrett’s Esophagus Ganapathy A. Prasad, M.D. Navtej S. Buttar,
Indications for gastrectomy after incomplete EMR for early gastric cancer Hideki Nagano1,4, Shigekazu Ohyama1, Tetsu Fukunaga1, Yasuyuki Seto1, Junko Fujisaki2,
Perforation of duodenal 2nd portion after EMR-C for carcinoid tumor
Microcarcinoidosis of the Stomach
ENDOSCOPIC MUCOSAL RESECTION OF NON INVASIVE DUODENAL CARCINOID
Treatment of superficial neoplastic lesion of esophagus
Date of download: 10/18/2017 Copyright © ASME. All rights reserved.
GASTER, DUODENUM, AND PANCREAS
Safety and Efficacy of Secondary Endoscopic Submucosal Dissection for Residual Gastric Carcinoma after Primary Endoscopic Submucosal Dissection Digestion.
Cancer Staging:Gastric Cancer Medical Univ
Stomach cancer Also called gastric cancer is cancer arising from stomach tissue.it is uncontrolled cell growth of stomach layers lead to dysfunction of.
Gastric cancer.
Polyps of the Colon and Rectum
蘇炳睿/ 趙盈瑞/沈延盛 國立成功大學醫學院附設醫院 一般外科
STOMACH CANCER BY DR: ALI ALWAILY/MD.
How to Approach a Patient With Ampullary Lesion
Prognosis of lip cancer is quite good, with a five year survival rate at 95% -100% for lower lip carcinoma and 58% for upper lip carcinoma. Intraoral cancer.
Christopher G. Chapman, MD, Irving Waxman, MD, FASGE  VideoGIE 
Novel approach to endoscopic submucosal dissection of a large gastroesophageal junction mass by use of the mucosal bridge technique  Salmaan Jawaid, MD,
Fig. 2. One case of recurrence out of 12 adult patients with totally resected ependymomas without anaplastic pathology or postoperative adjuvant treatment.
Neuroendocrine tumours of the stomach
Presentation transcript:

53 y/o Upper abd pain/burning, reflux 9/2011 – EGD – polypoid lesion in stomach on EGD, started on omeprazole – Path – carcinoid, invasive to muscularis, metaplasia

10/2011 Hampton VA GI – EGD – several polypoid lesions, 1 lesion ulcerated, – Biopsy – carcinoid – Heme/Onc, Surgery evals 2/2012 Hampton – Attempted endoscopic resection Masses 2cm, 5cm, 8cm from GEJ 4/2012 Richmond VA

PMH/PSH: none Meds: omeprazole Social: ½ PPD tobacco, quit drugs/EtOH 4 years ago

5/8 – Exploration – gastrectomy Path – GEJ carcinoids, posterior wall – 0/10 nodes – 2.1 cm – Well differentiated, into muscularis

Type 1 – associated with atrophic gastritis Type 2 – sporatic Type 3 – associated with gastrinoma, MEN1 (type 2 in other system) Type 4 – other endocrine carcinomas or mixed tumors

Survival Type 1 – 5y=96.1%, 10y=73.9% Type 2 – 5y=95%+ Type 3 – 5y=50-75% Type 4 – 5y=33%, 10y=22%

Treatment recommendations Type 1- endoscopic removal of 5 lesions up to 10mm antrectomy for >5 lesions to 10mm lesions >10mm require surgical removal serosal involvement or spread outside stomach – gastrectomy Type 2- treat gastrinoma, endoscopic 10mm Type 3,4- laparotomy, local excision Treatment recommendations Type 1- EMR of 5 lesions up to 10mm, confined to submucosa, confirm neg margins EGD every 6-12m recurrence – surgical resection based on extent of disease consider antrectomy – some support in literature lesions>10mm/more invasive – wedge resection, subtotal/total gastrectomy based on extent of disease case reports of octreotide use in non-surgical candidates Type 2- treat gastrinoma, endoscopic 10mm Type 3- laparotomy, total or near total gastrectomy, node dissection (more aggressive)

Treatment recommendations Type 1- EMR, polypectomy of 5 lesions up to 10mm, confined to submucosa consider antrectomy – some support in literature consider observation/repeat EGD lesions<10mm case reports of octreotide use in non-surgical candidates Type 2- treat gastrinoma, endoscopic <10mm Type 3- laparotomy, total or near total gastrectomy, node dissection (more aggressive)